A randomised controlled trial of patient self management of oral anticoagulation compared to standard care

ISRCTN ISRCTN19313375
DOI https://doi.org/10.1186/ISRCTN19313375
Protocol serial number G9900263
Sponsor Medical Research Council (MRC) (UK)
Funder Medical Research Council (UK)
Submission date
23/10/2000
Registration date
23/10/2000
Last edited
21/07/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Haematological Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr A Fitzmaurice
Scientific

The Department of Primary Care and General Practice
The Medical School
The University of Birmingham
Birmingham
B15 2TT
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymSMART: Self-Management of Anticoagulation, a Randomised Trial
Study objectivesThe null hypothesis is that patients managing their own anticoagulation can achieve as good therapeutic control as patients receiving standard care.

Please note that as of 07/02/2007 this record was updated to include the current target number of participants. The previous target number of participants at the time of registration was 660.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedAnticoagulant therapy
InterventionThe intervention comprises a training programme to enable patients to undertake oral anticoagulation monitoring at home.
Intervention typeOther
Primary outcome measure(s)

1. Therapeutic international normalised ratio (INR) control
2. Bleeding and thrombotic complications

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/06/2003

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration512
Key inclusion criteriaAll patients aged over 18 receiving warfarin therapy
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/09/2000
Date of final enrolment30/06/2003

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

The Department of Primary Care and General Practice
Birmingham
B15 2TT
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 05/11/2005 Yes No
Results article results 01/04/2011 Yes No
Protocol article protocol 18/09/2003 Yes No